Cefepime Inj. 250mg/ 1gm / 2gm Cephalosporins (Dry Powder Injection) Vial

What is Cefepime Inj. 250mg/ 1gm / 2gm Cephalosporins (Dry Powder Injection) Vial?

Cefepime Injection is a fourth-generation cephalosporin antibiotic containing cefepime as its active ingredient. Available in the stated strengths of 250mg, 1gm and 2gm, it is presented as a dry powder injection for preparation according to approved instructions. Cefepime is used in clinical settings to treat selected bacterial infections caused by susceptible organisms, with the specific indication determined by the approved prescribing information.

Uses / Indications

Cefepime is a broad-spectrum cephalosporin antibiotic used for certain bacterial infections caused by susceptible organisms. Depending on the approved product information and local clinical guidance, its established uses may include:

• Pneumonia caused by susceptible bacteria.

• Complicated urinary tract infections, including selected cases of pyelonephritis.

• Certain skin and skin-structure infections.

• Selected intra-abdominal infections when used with appropriate additional therapy, where indicated.

• Febrile neutropenia in appropriate clinical circumstances.

• Other serious bacterial infections when supported by susceptibility results and applicable treatment guidelines.

The exact indications depend on the product’s approved prescribing information, patient circumstances and local regulatory requirements. Cefepime does not treat viral infections such as influenza or the common cold.

6. Benefits

• Contains cefepime, an established fourth-generation cephalosporin antibiotic.

• Available in the supplied strengths of 250mg, 1gm and 2gm.

• Dry powder presentation allows preparation in accordance with product-specific instructions.

• Used in clinical settings for appropriate bacterial infections caused by susceptible organisms.

• Supports pharmaceutical sourcing requirements through Kelar Pharmachem India, a pharmaceutical sourcing and export company.

Treatment outcomes depend on correct antibiotic selection, appropriate administration and the susceptibility of the causative organism.

7. Side Effects

Common Side Effects

Potential adverse effects associated with cefepime include:

• Diarrhoea.

• Nausea or vomiting.

• Skin rash.

• Local reactions associated with administration.

• Headache.

The effects experienced and their frequency may vary between patients.

Less Common or Serious Side Effects

• Serious allergic reactions, including anaphylaxis.

• Antibiotic-associated diarrhoea, including possible Clostridioides difficile infection.

• Changes in blood cell counts.

• Abnormal liver function tests.

• Kidney-related complications in susceptible patients.

• Neurological reactions, including confusion, altered consciousness, myoclonus or seizures, particularly when cefepime accumulates in patients with renal impairment.

Seek prompt medical assessment if a serious allergic reaction, severe diarrhoea or neurological symptoms occur. Refer to the approved product information for the complete safety profile.

8. How Does It Work?

Cefepime belongs to the beta-lactam class of antibiotics and is classified as a fourth-generation cephalosporin. It binds to bacterial penicillin-binding proteins and interferes with the synthesis of peptidoglycan, an essential component of the bacterial cell wall. This weakens the cell wall and can lead to the death of susceptible bacteria.

Its activity depends on the organism’s susceptibility. Appropriate clinical assessment and microbiological testing, where indicated, help guide treatment.

9. Dosage Guidelines

The dosage of Cefepime Injection depends on the infection being treated, its severity, the causative organism, the patient’s age and weight where relevant, renal function and the approved prescribing information.

• The supplied strengths are 250mg, 1gm and 2gm.

• The appropriate strength and dose must be selected by a qualified healthcare professional.

• Dosage adjustment may be required in patients with impaired renal function.

• Reconstitution, dilution and administration must follow the specific product instructions.

• Preparation and administration must be carried out by appropriately qualified healthcare professionals.

The exact dose and treatment duration should follow the approved product information and the recommendation of a qualified healthcare professional.

10. When Not to Use

Cefepime should not be used in patients with a known serious hypersensitivity to cefepime or other product components, or where the approved product information identifies a relevant contraindication.

Before administration:

• Review any previous allergic reaction to cephalosporins.

• Assess a history of serious reactions to penicillins or other beta-lactam antibiotics.

• Consider renal function and the risk of drug accumulation.

• Follow the specific product’s approved contraindications and precautions.

A penicillin allergy does not automatically make every cephalosporin contraindicated. The type and severity of the previous reaction should be assessed by a qualified healthcare professional.

11. Drug / Product Interactions

Potential interactions should be assessed against the approved prescribing information and the patient’s current medicines.

• Aminoglycosides: Concurrent use may warrant monitoring of renal function because of potential kidney-related risks.

• Potent diuretics: Certain combinations may require additional renal monitoring.

• Other medicines affecting renal function: Review concurrent treatment where there is a risk of impaired cefepime clearance.

• Laboratory tests: Cefepime may affect certain laboratory test results, depending on the testing method.

These considerations are not a substitute for a full interaction review. Healthcare professionals should assess the patient’s medication history and the product-specific information before treatment.

12. Safety Advice

• Use only under appropriate medical supervision.

• Check the patient’s allergy history before administration.

• Assess renal function and adjust dosage when required.

• Follow the prescribed dose and intended route.

• Use the approved instructions for preparation, dilution and administration.

• Monitor for allergic reactions, neurological changes and other clinically significant adverse effects.

• Use antibiotics only for appropriate bacterial indications to support antimicrobial stewardship.

Cefepime-related neurological toxicity is an important consideration in patients with renal impairment, particularly if dosage is not appropriately adjusted.

13. General Instructions

• Verify the product name, strength, batch number and expiry date before use.

• Inspect the vial and container closure for damage.

• Follow the product-specific instructions for reconstitution and administration.

• Maintain appropriate aseptic handling practices.

• Do not use products with damaged containers or those that fail applicable quality checks.

• Follow approved instructions for compatibility and use after reconstitution.

• Dispose of unused medicine and clinical waste according to applicable procedures.

Do not assume a universal diluent, reconstitution volume, administration method or post-reconstitution storage period for all cefepime products.

14. Special Dietary / Lifestyle Tips

No universal dietary restriction applies specifically to cefepime dry powder injection.

• Follow the treatment plan provided by the healthcare professional.

• Complete the prescribed course according to professional instructions.

• Do not share antibiotics with others.

• Report persistent diarrhoea, rash, confusion or other concerning symptoms promptly.

• Follow individual fluid-intake advice if kidney disease or another condition requires fluid restrictions.

Dietary and lifestyle advice should be tailored to the patient’s overall medical condition.

15. Comparison with Other Treatments

Cefepime is a fourth-generation cephalosporin. Its spectrum and clinical role differ from those of other cephalosporins and antibiotic classes.

Antibiotic selection should consider the suspected or confirmed pathogen, susceptibility results, infection site, severity, patient characteristics and local clinical guidance. Cefepime is not automatically preferable to other antibiotics for every infection.

16. Precautions & Warnings

• Allergic reactions: Assess previous reactions to cefepime, cephalosporins and other beta-lactam antibiotics.

• Renal impairment: Dosage adjustment is important to reduce the risk of accumulation and neurological toxicity.

• Neurological effects: Monitor for confusion, altered consciousness, myoclonus or seizures, particularly in patients with renal impairment.

• Antibiotic-associated diarrhoea: Severe or persistent diarrhoea requires medical assessment.

• Blood and liver parameters: Monitoring may be appropriate according to the patient’s clinical circumstances and product information.

• Antimicrobial resistance: Avoid inappropriate use and follow local antibiotic stewardship guidance.

• Special populations: Pregnancy, breastfeeding and paediatric use should be assessed according to the approved product information.

17. Can I Use It With Other Medicines?

Cefepime may be used alongside other medicines when clinically appropriate, but concurrent treatment requires a professional review of potential interactions and patient-specific risks.

Inform the healthcare professional about:

• Prescription and non-prescription medicines.

• Other antibiotics.

• Aminoglycosides and medicines that may affect renal function.

• Diuretics and other relevant treatments.

• Vitamins and supplements.

Physical compatibility must be confirmed separately before cefepime is mixed with another medicine in a syringe, infusion container or administration line. Do not mix medicines without verified compatibility instructions.

18. Storage

Store according to the manufacturer’s approved product labelling. Refer to the product packaging or package insert for the applicable storage conditions.

Storage requirements for the dry powder may differ from those for the prepared solution. Any temperature limits, protection requirements and permitted period of use after reconstitution must be confirmed from the specific product documentation.

19. Frequently Asked Questions (FAQs)

1. What is Cefepime Injection used for?

Cefepime is used to treat selected bacterial infections caused by susceptible organisms. The exact indications depend on the approved product information and clinical assessment.

2. Which strengths are available?

The supplied strengths are 250mg, 1gm and 2gm. The specific presentation should be confirmed against the approved product specification.

3. What type of antibiotic is cefepime?

Cefepime is a fourth-generation cephalosporin antibiotic belonging to the beta-lactam class.

4. How is Cefepime Dry Powder Injection prepared?

A qualified healthcare professional must prepare it according to the approved product-specific instructions. The appropriate diluent, preparation volume and administration procedure must be verified from the product documentation.

5. Can cefepime be used in patients with kidney problems?

It may be used when clinically appropriate, but renal impairment can require dosage adjustment. Inadequate adjustment can increase the risk of neurological toxicity.

6. What are the important side effects of cefepime?

Potential adverse effects include diarrhoea, nausea, rash and injection-related reactions. Serious allergic reactions and neurological toxicity are important risks requiring prompt assessment.

7. How should Cefepime Injection be stored?

Follow the manufacturer’s approved product labelling. Storage conditions before and after reconstitution should be confirmed from the product-specific documentation.

8. Is Cefepime Injection available for pharmaceutical export?

Kelar Pharmachem India is a pharmaceutical sourcing and export company. Availability, packing configurations, destination-market requirements and supporting documentation should be confirmed with the company.

This information is for pharmaceutical product reference and does not replace approved prescribing information or professional medical advice.